Imaging Core
成像核心
基本信息
- 批准号:10620686
- 负责人:
- 金额:$ 24.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-04-15 至 2024-03-31
- 项目状态:已结题
- 来源:
- 关键词:AccelerationAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaAmyloidAwardBiological MarkersBlood VesselsClassificationClinicalCollaborationsCommunicationComparative StudyDataData SetDevelopmentDiagnosisDiagnosticDifferential DiagnosisEarly DiagnosisEarly Onset Alzheimer DiseaseEducationEnsureEvaluationFacultyFiberFrontotemporal Lobar DegenerationsFunctional Magnetic Resonance ImagingFundingFutureGoalsGrantHeterogeneityHuman ResourcesImageImage AnalysisIndividualIndustryInheritedInjuryInternationalIntervention TrialLinkLiquid substanceMRI ScansMachine LearningMagnetic Resonance ImagingMassachusettsMeasuresMethodsMissionMonitorMulti-Institutional Clinical TrialMultimodal ImagingNerve DegenerationOutcomeParticipantPatternPhenotypePositron-Emission TomographyProcessProtocols documentationRadiopharmaceuticalsResearchResearch PersonnelResearch Project GrantsResourcesScanningSoftware ToolsStudentsSyndromeTechniquesTissuesTracerTrainingUnited States National Institutes of HealthValidationWorkanalytical methodanalytical toolbiological researchcareercerebral atrophyclinical practicecohortconnectomecost effectivedata toolsdisease heterogeneityimage archival systemimaging facilitiesimaging modalityinnovationinterestmultidisciplinaryneuroimagingneuroimaging markerneuroinflammationneuropathologynext generationnovelpreclinical studyprognosticationrecruitresearch studytau Proteinsvascular injuryvirtualwhite matter
项目摘要
Massachusetts Alzheimer's Disease Research Center: Imaging Core
The Imaging Core of the Massachusetts Alzheimer's Disease Research Center (MADRC) supports and
performs imaging research to understand a variety of types of heterogeneity in Alzheimer's disease and
Alzheimer's disease related disorders (AD/ADRD) and accelerate progress towards a cure. We carry out
core functions in Aims 1, 2, and 3 marshaling resources to enhance the research mission through the
support and contributions to imaging components of MADRC-affiliated local and national research projects and
the development of uniform imaging protocols that contribute to novel efforts to understand heterogeneity, such
as the classification of MADRC Research Cohort participants into the "ATVN" (amyloid, tau, vascular,
neurodegeneration) biological research framework. In Aims 4, 5, and 6, we develop and implement new
strategies and accelerate progress towards a cure in our refinement and validation of novel PET and
structural and functional MRI methods. These innovative imaging methods are evaluated in the MADRC
Research Cohort, leveraging this deeply phenotyped cohort of participants spanning diverse AD/ADRD
diagnoses to make the process of innovation cost-effective (many participants have already been imaged and
so these measures can be used to facilitate strategic recruitment; e.g., of amyloid “positive” subjects) and
value-added (by comparing novel imaging measures with those we understand well already). In Aims 7 and 8
we build the future by providing expertise, education, training and data and software tools to faculty, trainees
and students for best practices in imaging research and by providing education to researchers, clinicians and
the public on the advances, utility and responsible interpretation of imaging data in AD and ADRD research
and ultimately clinical practice.
马萨诸塞州阿尔茨海默氏病研究中心:成像核心
马萨诸塞州阿尔茨海默氏病研究中心(MADRC)的成像核心支持和
进行成像研究以了解阿尔茨海默氏病和
阿尔茨海默氏病有关的疾病(AD/ADRD),并加速了治愈的进步。我们执行
目标1、2和3的核心功能通过
对与MADRC相关的地方和国家研究项目的成像组成部分的支持和贡献以及
统一成像方案的发展有助于理解异质性的新努力,这样
随着MADRC研究队列参与者的分类为“ ATVN”(淀粉样蛋白,tau,血管,
神经变性)生物学研究框架。在目标4、5和6中,我们开发和实施新的
策略并加速进步,以治愈我们对新型宠物的改进和验证
结构和功能性MRI方法。这些创新的成像方法在MADRC中进行了评估
研究队列,利用了跨越潜水员广告/adrd的参与者的深层表型队列
诊断以实现创新成本效益的过程(许多参与者已经成像,并且
因此,这些措施可用于促进战略招聘;例如,淀粉样蛋白的“阳性”主体)和
增值(通过将新颖的成像措施与我们已经很好理解的措施进行比较)。在目标7和8中
我们通过为学员提供专业知识,教育,培训和数据以及软件工具来建立未来
以及学生在成像研究方面的最佳实践,并通过向研究人员,临床医生和
公众在AD和ADRD研究中对成像数据的进步,实用性和负责任的解释
最终是临床实践。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BRADFORD C DICKERSON其他文献
BRADFORD C DICKERSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BRADFORD C DICKERSON', 18)}}的其他基金
Robust detection of atrophy over short intervals in AD and FTLD
在 AD 和 FTLD 中短时间间隔内对萎缩进行稳健检测
- 批准号:
10633960 - 财政年份:2023
- 资助金额:
$ 24.3万 - 项目类别:
ADRC Consortium for Clarity in ADRD Research Through Imaging
ADRC 联盟通过成像来明确 ADRD 研究
- 批准号:
10803806 - 财政年份:2023
- 资助金额:
$ 24.3万 - 项目类别:
Toward Personalized Prognosis and Outcomes in Primary Progressive Aphasia
原发性进行性失语症的个性化预后和结果
- 批准号:
10634041 - 财政年份:2023
- 资助金额:
$ 24.3万 - 项目类别:
Neuromodulation of brain network function in preclinical and prodromal Alzheimer's Disease
阿尔茨海默病临床前和前驱期脑网络功能的神经调节
- 批准号:
10589289 - 财政年份:2023
- 资助金额:
$ 24.3万 - 项目类别:
Computational psycholinguistic analysis of speech samples in PPA and AD and FTD
PPA、AD 和 FTD 中语音样本的计算心理语言学分析
- 批准号:
10373191 - 财政年份:2022
- 资助金额:
$ 24.3万 - 项目类别:
Computational psycholinguistic analysis of speech samples in PPA and AD and FTD
PPA、AD 和 FTD 中语音样本的计算心理语言学分析
- 批准号:
10563169 - 财政年份:2022
- 资助金额:
$ 24.3万 - 项目类别:
Characterizing sleep brain dynamics associated with Alzheimer's disease pathology and progression in humans using EEG source localization and PET
使用 EEG 源定位和 PET 表征与人类阿尔茨海默病病理学和进展相关的睡眠大脑动力学
- 批准号:
10590969 - 财政年份:2022
- 资助金额:
$ 24.3万 - 项目类别:
Use of machine learning to quantify cognitive function in AD, FTD, and DLB
使用机器学习来量化 AD、FTD 和 DLB 中的认知功能
- 批准号:
10288487 - 财政年份:2021
- 资助金额:
$ 24.3万 - 项目类别:
Muli-scale Structural Imaging of Alzheimer's Disease Neuropathology and Neurodegeneration
阿尔茨海默病神经病理学和神经变性的多尺度结构成像
- 批准号:
10207104 - 财政年份:2021
- 资助金额:
$ 24.3万 - 项目类别:
Use of machine learning to quantify cognitive function in AD, FTD, and DLB
使用机器学习来量化 AD、FTD 和 DLB 中的认知功能
- 批准号:
10468302 - 财政年份:2021
- 资助金额:
$ 24.3万 - 项目类别:
相似海外基金
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
- 批准号:
10749539 - 财政年份:2024
- 资助金额:
$ 24.3万 - 项目类别:
Centrally-linked longitudinal peripheral biomarkers of AD in multi-ethnic populations
多种族人群中 AD 的中心连锁纵向外周生物标志物
- 批准号:
10555723 - 财政年份:2023
- 资助金额:
$ 24.3万 - 项目类别:
Impact of Mitochondrial Lipidomic Dynamics and its Interaction with APOE Isoforms on Brain Aging and Alzheimers Disease
线粒体脂质组动力学及其与 APOE 亚型的相互作用对脑衰老和阿尔茨海默病的影响
- 批准号:
10645610 - 财政年份:2023
- 资助金额:
$ 24.3万 - 项目类别:
Developing a nonpharmacological pain intervention for community dwelling older adults with dementia
为社区居住的痴呆症老年人开发非药物疼痛干预措施
- 批准号:
10644490 - 财政年份:2023
- 资助金额:
$ 24.3万 - 项目类别: